It is also a vital mediator of cytokine storm, which has been linked to severe COVID-19.11,12 We previously developed a CD147 humanized antibody, meplazumab, which was demonstrated as a receptor blocker and could effectively inhibit the viral entry and cytokine storm caused by SARS-CoV-2. This evidence concerns the gene BSG and COVID-19.